Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

One Small Step For US FDA, But Maybe A Giant Leap For SaMDs

Jul 23 2019

• By Ferdous Al-Faruque

FDABldg1ExteriorWithCircle_1200x675

Related Content

'Excellence' In Health-Software Design: US FDA Taps Nine Firms To Figure Out What That Means

Sep 26 2017

2019 Will Be Testing Period For US FDA's Novel Pre-Cert Paradigm For Digital Health

Jan 08 2019

Pre-Cert Program Will Start Off Slow With De Novo Framing, But Big Questions Remain

Jan 14 2019

Related Companies

Apple Inc.

Samsung Bioepis Co., Ltd.

Verily

Additional Topics

Regulation Digital Health FDA Review Pathway Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.